Failed to fetch strategies that include SRRK
Failed to fetch stock correlation
Current Value
$44.101 Year Return
Current Value
$44.101 Year Return
Finnhub
Scholar Rock , a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other serious diseases where protein growth...
Yahoo
CAMBRIDGE, Mass., January 08, 2025--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today provided recent corporate updates and highlighted upcoming priorities for 2025.
Yahoo
CAMBRIDGE, Mass., January 02, 2025--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced that management will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 9:45 a.m. PT (12:45 p.m. ET).
SeekingAlpha
Scholar Rock has a promising SMA treatment. Apitegromab's unique approach targets precursor myostatin. See why SRRK stock is hold rated.
SeekingAlpha
I analyze Scholar Rock's promising Phase 3 results for SMA drug, but warn of financial challenges and recommend a Hold rating. Read more here.
Finnhub
CAMBRIDGE - Scholar Rock , a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other serious diseases where...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TRMB | -<0.01% | $18.05B | +49.60% | 0.00% |
CBU | <0.01% | $3.29B | +31.07% | 2.87% |
ABCB | <0.01% | $4.41B | +27.90% | 1.01% |
BACK | -0.01% | $2.66M | -40.81% | 0.00% |
FR | -0.01% | $6.80B | -1.76% | 2.89% |
AAOI | 0.01% | $1.48B | +85.80% | 0.00% |
GE | 0.01% | $194.53B | +75.32% | 0.62% |
JMIA | -0.01% | $382.36M | +23.84% | 0.00% |
BTI | 0.01% | $79.05B | +22.24% | 8.31% |
MFIC | 0.01% | - | - | 11.30% |
SMAR | 0.01% | $7.88B | +22.85% | 0.00% |
EVGO | -0.02% | $386.61M | +35.98% | 0.00% |
AMG | 0.02% | $5.61B | +23.80% | 0.02% |
MLM | -0.02% | $32.47B | +5.61% | 0.57% |
HCSG | -0.02% | $873.63M | +22.63% | 0.00% |
PCT | 0.02% | $1.63B | +210.56% | 0.00% |
AMAT | -0.02% | $151.74B | +16.30% | 0.80% |
GTLB | 0.02% | $10.42B | -1.38% | 0.00% |
HOPE | 0.02% | $1.45B | +5.73% | 4.67% |
DUOL | 0.02% | $15.03B | +71.06% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
UVE | -43.20% | $549.88M | +18.07% | 3.27% |
HCI | -40.11% | $1.28B | +35.73% | 1.31% |
RNR | -35.93% | $13.35B | +22.52% | 0.61% |
EG | -32.72% | $15.48B | -2.35% | 2.13% |
ACIC | -27.80% | $582.80M | +4.38% | 0.00% |
ACGL | -27.33% | $36.16B | +27.99% | 0.00% |
HRTG | -27.00% | $344.89M | +78.41% | 0.00% |
CB | -25.75% | $110.26B | +18.91% | 1.31% |
RLI | -24.89% | $7.13B | +12.74% | 1.45% |
AIZ | -24.44% | $10.86B | +27.07% | 1.40% |
ALL | -22.85% | $50.60B | +24.97% | 1.92% |
HALO | -19.56% | $7.04B | +58.52% | 0.00% |
PGR | -19.28% | $143.84B | +44.51% | 2.34% |
BRO | -18.83% | $30.30B | +42.89% | 0.51% |
PLMR | -18.66% | $2.87B | +75.64% | 0.00% |
DUK | -18.19% | $84.25B | +13.77% | 3.80% |
L | -17.86% | $18.75B | +20.41% | 0.29% |
AXS | -17.63% | $7.53B | +62.82% | 1.95% |
CINF | -16.99% | $22.34B | +31.99% | 2.25% |
TRV | -16.88% | $55.02B | +22.19% | 1.72% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
LIT | 22.27% | $1.07B | 0.75% |
REMX | 20.99% | $241.92M | 0.56% |
GXC | 20.83% | $388.10M | 0.59% |
CQQQ | 19.03% | $631.36M | 0.65% |
FLCH | 18.33% | $142.24M | 0.19% |
MCHI | 17.66% | $4.92B | 0.6% |
CXSE | 17.19% | $367.78M | 0.32% |
CHIQ | 15.68% | $199.51M | 0.65% |
BATT | 15.20% | $65.99M | 0.59% |
DBO | 15.00% | $220.74M | 0.77% |
DBE | 13.80% | $50.40M | 0.77% |
JPEM | 13.53% | $311.10M | 0.44% |
DVYE | 13.08% | $624.96M | 0.49% |
IDRV | 13.04% | $164.79M | 0.47% |
FNDE | 12.76% | $6.06B | 0.39% |
AIA | 12.55% | $703.35M | 0.5% |
EDIV | 12.23% | $529.03M | 0.65% |
PBW | 12.20% | $297.37M | 0.65% |
AAXJ | 12.06% | $2.41B | 0.72% |
SPEM | 12.04% | $9.56B | 0.07% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IAK | -21.37% | $736.15M | 0.39% |
KIE | -19.41% | $895.48M | 0.35% |
TPMN | -16.98% | $41.98M | 0.65% |
FPEI | -15.96% | $1.54B | 0.85% |
LDSF | -15.10% | $126.19M | 0.75% |
LMBS | -14.74% | $4.68B | 0.64% |
RSPA | -13.09% | $270.72M | 0% |
FSIG | -11.89% | $1.26B | 0.55% |
XLU | -11.58% | $16.48B | 0.09% |
KMLM | -11.38% | $330.04M | 0.9% |
IDU | -11.10% | $1.16B | 0.39% |
VPU | -10.94% | $6.60B | 0.1% |
FUTY | -10.34% | $1.62B | 0.084% |
VRP | -10.26% | $1.89B | 0.5% |
SHV | -9.24% | $18.98B | 0.15% |
HFND | -9.17% | $32.20M | 1.22% |
ICSH | -8.95% | $5.26B | 0.08% |
CGSD | -8.58% | $940.48M | 0.25% |
CTA | -8.55% | $553.08M | 0.76% |
FDLO | -8.52% | $1.33B | 0.16% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GOVZ | -<0.01% | $280.90M | 0.1% |
SDOG | <0.01% | $1.20B | 0.36% |
LCTD | -0.01% | $247.24M | 0.2% |
IEFA | -0.01% | $117.00B | 0.07% |
THTA | 0.01% | $36.94M | 0.49% |
HEDJ | 0.02% | $1.52B | 0.58% |
KBWD | -0.02% | $404.21M | 2.02% |
JVAL | -0.03% | $702.92M | 0.12% |
PIZ | 0.03% | $169.70M | 0.8% |
ENZL | 0.03% | $76.10M | 0.5% |
VTIP | 0.03% | $12.08B | 0.04% |
EPOL | 0.05% | $196.40M | 0.59% |
XCEM | -0.06% | $1.12B | 0.16% |
AOK | -0.06% | $729.55M | 0.15% |
DIVI | -0.06% | $975.78M | 0.09% |
CNBS | -0.06% | $11.68M | 0.77% |
IEV | -0.07% | $1.48B | 0.61% |
BBH | -0.07% | $394.56M | 0.35% |
ISCF | 0.07% | $505.68M | 0.23% |
FRI | -0.07% | $165.47M | 0.5% |